Table 3.
Formulary Coverage Within the Top 5 Therapeutic Classes, by Plan*
| Antidiabetics (8 Drugs) |
Diuretics (8 Drugs) |
Beta Blockers (10 Drugs) |
ACE / ARBs (22 Drugs) |
Antilipidemics (11 Drugs) |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tier | NC | 1 | 2 | 3 | NC | 1 | 2 | 3 | NC | 1 | 2 | 3 | NC | 1 | 2 | 3 | NC | 1 | 2 | 3 |
| Part D Plans | ||||||||||||||||||||
| A | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 7 | 5 | 0 | 5 | 6 | 0 |
| B | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 7 | 5 | 0 | 5 | 6 | 0 |
| C | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 7 | 5 | 0 | 5 | 6 | 0 |
| D | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 4 | 10 | 4 | 4 | 2 | 5 | 3 | 1 |
| E | 0 | 7 | 5 | 1 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 5 | 7 | 0 | 5 | 5 | 1 |
| F | 1 | 7 | 5 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 8 | 10 | 4 | 0 | 3 | 5 | 3 | 0 |
| G | 0 | 7 | 5 | 1 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 4 | 8 | 0 | 5 | 4 | 2 |
| H | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 1 | 8 | 1 | 0 | 6 | 10 | 6 | 0 | 1 | 5 | 5 | 0 |
| I | 1 | 7 | 5 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 5 | 10 | 7 | 0 | 2 | 4 | 5 | 0 |
| J | 1 | 7 | 5 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 6 | 10 | 6 | 0 | 4 | 4 | 3 | 0 |
| Non-Part D Plans | ||||||||||||||||||||
| Medi-Cal | 0 | 13 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 22 | 0 | 0 | 0 | 11 | 0 | 0 |
| TRICARE | 0 | 8 | 5 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 9 | 11 | 2 | 0 | 5 | 5 | 1 |
| CALPERS | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 10 | 2 | 0 | 5 | 5 | 1 |
| Blue Cross | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 5 | 7 | 0 | 5 | 3 | 3 |
| FEP | 0 | 7 | 6 | 0 | 0 | 8 | 0 | 0 | 0 | 9 | 1 | 0 | 0 | 10 | 6 | 6 | 0 | 5 | 5 | 1 |
| VA | 7 | 6 | 0 | 0 | 1 | 7 | 0 | 0 | 2 | 8 | 0 | 0 | 12 | 10 | 0 | 0 | 5 | 6 | 0 | 0 |
| Kaiser | 4 | 7 | 2 | 0 | 0 | 8 | 0 | 0 | 1 | 8 | 1 | 0 | 11 | 10 | 1 | 0 | 6 | 5 | 0 | 0 |
Source: Fingertip Formulary, 2007 and Verispan’s Vector One National Audit.
*
Among the Top-300 selling drugs based on total scripts. NC=Not covered. ACE refers to Angiotensin-converting enzyme inhibitors. ARBs refer to Angiotensin II Receptor Blockers.